HeraMED Ltd. ( (AU:HMD) ) has shared an announcement.
HeraMED Ltd. reported a 20.6% decline in revenues for the year ending December 31, 2024, with a net loss of $5,490,578, marking a 19% improvement over the previous year’s loss. Despite the financial downturn, the company did not declare any dividends, and its net tangible assets per ordinary security increased to 0.23 cents, indicating a potential strengthening of its asset base.
More about HeraMED Ltd.
HeraMED Ltd. operates in the healthcare industry, focusing on innovative medical technology solutions. The company primarily develops and markets products aimed at improving maternal and fetal health monitoring.
YTD Price Performance: 10.0%
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €8.92M
Find detailed analytics on HMD stock on TipRanks’ Stock Analysis page.